SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950120-00-000009
Filing Date
2000-01-10
Accepted
2000-01-10 00:00:00
Documents
1
Group Members
BRUCE F. WESSONDAVID JAHNSGALEN EMPLOYEE FUND III, L.P.GALEN PARTNERS III L PGALEN PARTNERS III, L.P.GALEN PARTNERS INTERNATIONAL III, L.P.L. JOHN WILKERSONSRINI CONJEEVARAMWILLIAM R. GRANTZUBEEN SCHROFF

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D SC 13D/A 23204
  Complete submission text file 0000950120-00-000009.txt   25534
Mailing Address 214 CARNEGIE CENTER, SUITE 100 PRINCETON NJ 08540
Business Address 214 CARNEGIE CENTER, SUITE 100 PRINCETON NJ 08540 6095144744
DERMA SCIENCES INC (Subject) CIK: 0000892160 (see all company filings)

IRS No.: 232328753 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52013 | Film No.: 504000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 610 FIFTH AVE 5TH FL NEW YORK NY 10020
Business Address 610 FIFTH AVE 5TH FL NEW YORK NY 10020 2122184990
GALEN PARTNERS III L P (Filed by) CIK: 0001034486 (see all company filings)

IRS No.: 133930452 | State of Incorp.: DE | Fiscal Year End: 1231